In three evaluated eyes with classical CNV in patients treated with pegaptanib we noticed after @ years loss of @ letters , in eleven eyes with occult CNV we established loss of @ letters , and in two eyes with minimally classical CNV the average best-corrected visual acuity ( BCVA ) remained unchanged .